PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'IRCCS Istituto Ortopedico Galeazzi, 20161 Milan, Italy.\', \'Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano, 20122 Milan, Italy.\', \'Dipartimento di Scienze Biomediche e Cliniche \'L. Sacco\', Università degli Studi di Milano, 20157 Milan, Italy.\', \'Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.\', \'Department of Biomedical Sciences for Health, University of Milan, 20090 Segrate, Italy.\', \'Don C. Gnocchi Foundation, IRCCS, 20148 Milan, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 1019810.3390/ijms221910198
?:doi
?:hasPublicationType
?:journal
  • International journal of molecular sciences
is ?:pmid of
?:pmid
?:pmid
  • 34638539
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.26
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all